Jörg Köhl

Scientific Advisory Board Member at Kira Pharma

With over 30 years of experience in the medical and research realms, Dr. Jörg Köhl has been interested in the role of complement and other arms of innate immunity and the impact of this cross-talk on innate and adaptive immune responses. As Professor and Founding Director of the Institute for Systemic Inflammation Research, University of Lübeck (UzL), Germany, Dr. Köhl has successfully conducted numerous research studies and published almost 200 scientific research papers in reference to the complement therapeutic landscape with a focus on anaphylatoxic peptides C3a and C5a and their G-Protein-coupled receptors in experimental models of asthma, autoimmune diseases, transplantation and infections.

Dr. Köhl earned his undergraduate degree in the Study of Biology from Universities of Bochum and Mainz, alongside his medical degree from the University of Mainz, Germany.